Phenylpyruvic acid derivatives
Cayman Chemical PhenylpyruvIc AcId 10g
An active metabolite of phenylalanine; a biosynthetic precursor to 3-phenyllactic acid; inhibits G6PDH in rat brain homogenates at 0.6 and 1.2 mM; increases 3-phenyllactic acid levels in, and the antifungal activity of, the cell-free culture supernatant from lactic acid bacteria; urinary levels are increased in patients with PKU
Medchemexpress LLC Phenylpyruvic acid (sodium) | 114-76-1 | MFCD00002590 | 98.2% | 186.14 g/mol | C9H7NaO3 | 100 MG
Phenylpyruvic acid sodium is a white solid research reagent (CAS 114-76-1) used as an endogenous metabolite probe and as a precursor for phenyllactic acid. It is commonly employed in enzymatic and metabolic studies, antifungal activity assays, and as a synthetic intermediate or analytical standard. The material is supplied at high purity and should be stored sealed at cold temperatures to maintain stability.
- High purity suitable for analytical and research use.
- Functions as an endogenous metabolite probe in biochemical assays.
- Serves as a precursor for antifungal compound synthesis.
- Applicable to enzyme and metabolic pathway studies.
- Stable when stored sealed at refrigerated or frozen conditions.
Cayman Chemical 4-HydroxyphenylpyruvIc AcId 1g
An intermediate in aromatic amino acid metabolism; inhibits LPS-induced IL-6 and NO production in RAW 264.7 macrophages (IC50s = 2 and 0.5 mM, respectively); decreases serum starvation-induced mitochondrial superoxide production in EA.hy926 endothelial cells in vitro; increases survival in a rat model of hemorrhagic shock; serum and urinary levels are increased in patients with alkaptonuria
Cayman Chemical PhenylpyruvIc AcId 25g
An active metabolite of phenylalanine; a biosynthetic precursor to 3-phenyllactic acid; inhibits G6PDH in rat brain homogenates at 0.6 and 1.2 mM; increases 3-phenyllactic acid levels in, and the antifungal activity of, the cell-free culture supernatant from lactic acid bacteria; urinary levels are increased in patients with PKU
Cayman Chemical PhenylpyruvIc AcId 1g
An active metabolite of phenylalanine; a biosynthetic precursor to 3-phenyllactic acid; inhibits G6PDH in rat brain homogenates at 0.6 and 1.2 mM; increases 3-phenyllactic acid levels in, and the antifungal activity of, the cell-free culture supernatant from lactic acid bacteria; urinary levels are increased in patients with PKU
Selleck Chemical LLC Sodium phenylpyruvate S3351-100mg
Sodium phenylpyruvate (Phenylpyruvic acid sodium salt) inhibits amino acid formation and depresses oxygen consumption
Medchemexpress LLC Phenylpyruvic acid | 156-06-9 | MFCD00002589 | 99.9% | 164.16 | 25MG
Phenylpyruvic acid is a precursor of the antifungal compound phenyllactic acid. It affects the enzyme activity of the pentose phosphate pathway involved in the oxidative phase in rat brain homogenates and can reduce glucose-6-phosphate dehydrogenase activity. For research use only; not sold to patients.
- Can improve the antifungal activity of eight lactic acid bacterial strains when added to a defined growth medium.
- Demonstrates improved inhibitory activity against fungal bread contaminants such as *Aspergillus niger* and *Penicillium roqueforti*.
Medchemexpress LLC Phenylpyruvic acid sodium | 114-76-1 | MFCD00002590 | 98.2% | 186.14 g/mol | C9H7NaO3 | 250 MG
Phenylpyruvic acid sodium is the sodium salt of phenylpyruvic acid used as a research reagent. It is provided as a high-purity solid with supporting analytical and safety documentation, making it suitable for biochemical investigations and synthetic chemistry applications.
- High purity (98.2%) for reliable experimental results.
- Molecular weight 186.14 g/mol and formula C9H7NaO3.
- Supplied as a dry solid, convenient for weighing and storage.
- Includes certificate of analysis and safety data sheet for quality and handling information.
- Store sealed away from moisture; recommended solvent storage -80°C for 6 months or -20°C for 1 month.
- Suitable for biochemical research and synthetic applications.
Cayman Chemical PhenylpyruvIc AcId 5g
An active metabolite of phenylalanine; a biosynthetic precursor to 3-phenyllactic acid; inhibits G6PDH in rat brain homogenates at 0.6 and 1.2 mM; increases 3-phenyllactic acid levels in, and the antifungal activity of, the cell-free culture supernatant from lactic acid bacteria; urinary levels are increased in patients with PKU